Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 3
2006 2
2007 2
2008 1
2011 1
2012 5
2014 1
2015 6
2016 2
2017 3
2019 4
2020 3
2022 4
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Kállai J, Gindele R, Pénzes-Daku K, Balogh G, Bogáti R, Bécsi B, Katona É, Oláh Z, Ilonczai P, Boda Z, Róna-Tas Á, Nemes L, Marton I, Bereczky Z. Kállai J, et al. Among authors: nemes l. Int J Mol Sci. 2024 Mar 1;25(5):2893. doi: 10.3390/ijms25052893. Int J Mol Sci. 2024. PMID: 38474138 Free PMC article.
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.
Sidonio RF Jr, Boban A, Dubey L, Inati A, Kiss C, Boda Z, Lissitchkov T, Nemes L, Novik D, Peteva E, Taher AT, Timofeeva MA, Vilchevska KV, Vdovin V, Werner S, Knaub S, Djambas Khayat C. Sidonio RF Jr, et al. Among authors: nemes l. Blood Adv. 2024 Mar 26;8(6):1405-1414. doi: 10.1182/bloodadvances.2023011742. Blood Adv. 2024. PMID: 38237075 Free PMC article.
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.
von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, Matino D, Klamroth R, Weyand AC, Jimenez-Yuste V, Nogami K, Poloskey S, Winding B, Willemze A, Knobe K; XTEND-1 Trial Group. von Drygalski A, et al. N Engl J Med. 2023 Jan 26;388(4):310-318. doi: 10.1056/NEJMoa2209226. N Engl J Med. 2023. PMID: 36720133 Clinical Trial.
Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond.
Coriu D, Dirzu N, Zimta AA, Hambley BC, Liu X, Nemes L, Ghiaur G, Mahlangu J, Tomuleasa C. Coriu D, et al. Among authors: nemes l. Front Med (Lausanne). 2022 Apr 13;9:859710. doi: 10.3389/fmed.2022.859710. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492372 Free PMC article. No abstract available.
First experience of a hemophilia monitoring platform: florio HAEMO.
Zapotocka E, Batorova A, Bilic E, Boban A, Escuriola Ettingshausen C, Faganel Kotnik B, Hrdlickova R, Laguna P, Machal J, Nemes L, Zupan IP, Puras G, Zombori M. Zapotocka E, et al. Among authors: nemes l. Res Pract Thromb Haemost. 2022 Mar 13;6(2):e12685. doi: 10.1002/rth2.12685. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35308098 Free PMC article.
44 results